Korsana Biosciences, Inc. (KRSA)
31.31
-2.12
(-6.34%)
USD |
NASDAQ |
Oct 23, 16:00
31.44
+0.14
(+0.43%)
After-Hours: 20:00
Korsana Biosciences Price to Book Value : 3.742 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.742 |
| October 22, 2026 | 3.996 |
| October 21, 2026 | 3.889 |
| October 20, 2026 | 3.709 |
| October 19, 2026 | 3.754 |
| October 16, 2026 | 3.870 |
| October 15, 2026 | 4.022 |
| October 14, 2026 | 4.102 |
| October 13, 2026 | 3.784 |
| October 12, 2026 | 4.068 |
| October 09, 2026 | 4.054 |
| October 08, 2026 | 4.005 |
| October 07, 2026 | 3.783 |
| October 06, 2026 | 3.797 |
| October 05, 2026 | 3.672 |
| October 02, 2026 | 3.644 |
| October 01, 2026 | 3.729 |
| September 30, 2026 | 3.825 |
| September 29, 2026 | 4.064 |
| September 28, 2026 | 3.685 |
| September 25, 2026 | 3.705 |
| September 24, 2026 | 4.445 |
| September 23, 2026 | 3.860 |
| September 22, 2026 | 4.181 |
| September 21, 2026 | 3.969 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.182 |
| September 17, 2026 | 4.030 |
| September 16, 2026 | 3.733 |
| September 15, 2026 | 3.834 |
| September 14, 2026 | 3.778 |
| September 11, 2026 | 3.813 |
| September 10, 2026 | 2.935 |
| September 09, 2026 | 3.131 |
| September 08, 2026 | 2.811 |
| September 04, 2026 | 3.556 |
| September 03, 2026 | 4.150 |
| September 02, 2026 | 3.782 |
| September 01, 2026 | 3.489 |
| August 31, 2026 | 3.079 |
| August 28, 2026 | 3.171 |
| August 27, 2026 | 3.338 |
| August 26, 2026 | 3.472 |
| August 25, 2026 | 3.347 |
| August 24, 2026 | 3.288 |
| August 21, 2026 | 3.254 |
| August 20, 2026 | 3.405 |
| August 19, 2026 | 3.455 |
| August 18, 2026 | 3.447 |
| August 17, 2026 | 3.372 |
| August 14, 2026 | 3.171 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Climb Bio, Inc. | 2.443 |
| Q32 Bio, Inc. | 1.939 |
| Arrowhead Pharmaceuticals, Inc. | 17.59 |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 9.124 |
| PEG Ratio | -0.0211 |
| Price | 31.31 |
| Earnings Yield | -37.56% |
| Market Cap | 19.04M |
| PEGY Ratio | -0.0211 |